SCHEMBL19539121

SCHEMBL19539121

COc1ccc2c(c1)cc(SC)n2C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ HSD17B10 Q99714 3/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ MAPT P10636 3/20 0.46
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ HTT P42858 1/20 0.44
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ ROCK1 Q13464 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5071871 0.80 ALDH1A1 (0.58) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL16023576 0.75 ALDH1A1 (0.57) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL31202587 0.75 BRPF1 (0.61) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL16009898 0.75 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL9871331 0.74 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL24513132 0.72 BRPF1 (0.36) ALDH1A1HSD17B10HPGDLMNATSHR
SCHEMBL17680565 0.72 MAOA (0.59) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL11688871 0.72 KDM4E (0.54) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL4774449 0.72 L3MBTL1 (0.58) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD
SCHEMBL19531646 0.72 ALDH1A1 (0.58) ALDH1A1KDM4EHSD17B10L3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170312292-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF WUXI APPTEC (SHANGHAI) CO. LTD (CN) 2017-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170312292-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF EP300, CREBBP, HDAC1 ALDH1A1 1533/4885KDM4E 387/4885HSD17B10 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback